August 28, 1997Open Access

Valvular Heart Disease Associated with Fenfluramine–Phentermine

Structured PICO

Is fenfluramine-phentermine therapy associated with valvular heart disease?

Population

Patients receiving fenfluramine-phentermine therapy

Intervention

Fenfluramine-phentermine therapy

Outcome

Valvular heart diseasesafety

Fenfluramine-phentermine therapy raises significant safety concerns regarding the development of valvular heart disease and pulmonary hypertension.

Abstract

These cases arouse concern that fenfluramine-phentermine therapy may be associated with valvular heart disease. Candidates for fenfluramine-phentermine therapy should be informed about serious potential adverse effects, including pulmonary hypertension and valvular heart disease.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Heidi M. Connolly

Jack L. Crary

Michael D. McGoon

Journals

New England Journal of Medicine

Actions

Institutions

Mayo Clinic

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Valvular Heart Disease Associated with Fenfluramine–Phentermine

Structured PICO

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study